二零零五年,港大首次慶祝八位明德教授就職,為大學的歷史奠定重要的里程碑。
時至今日,已成立共一百一十九項明德教授席。
返回
李國賢博士

李國賢基金教授席 (腸胃學)

能對這個常存於我們心中,為人類福祉的共同追求略盡棉力。 

李國賢博士


待聘

待聘

前任明德教授

黎青龍

2011年就職

慢性B型肝炎影響著全球約4億人的生活,它也是導致肝癌的主要誘因之一。基於開創性的研究,黎教授揭示了關於肝炎病理和新療法的洞見。

自1971年起,黎教授任職於內科學系,隨後在系內的腸胃及肝臟科工作,該部門是香港領先的相關疾病轉診中心,並經常受理海外的會診。中心在瑪麗醫院設有住院服務,並為全院其他科系提供諮詢。

黎教授畢業時是港大醫學院的成績最優秀的學生,一年後,他加入醫學系。2003年來,他任醫學與肝臟病學教授。作為慢性B型肝炎專家,黎教授是世界最頂級的1%科學家之一。

他開創了對患慢性B型肝炎患兒的干擾素實驗,隨後帶頭開展了一系列全新的抗病毒藥物、核苷類似物的實驗,包括拉米夫定(1998年獲得許可牌照)、恩替卡韋(2006年獲得許可牌照)及替比夫定(2007年獲得許可牌照)。這三項研究均在《新英格蘭醫學雜誌》上發表,黎教授為第一作者。恩替卡韋現被認為是治療慢性B型肝炎首選的三種藥劑之一,被證實對降低肝纖維化有長期療效。

黎教授也是開展防治B型肝炎疫苗實驗的先驅之一。該項目創下了最持久的疫苗隨訪數據紀錄,無需加強劑量,疫苗在22年後依然有效。

黎教授應邀開展了許多受人矚目的講座,包括2005年度美國肝髒病研究協會頗受尊崇的萊昂希夫最新進展演講。他是兩輯《B型肝炎病毒》專書的合著者,發表過逾400篇學術期刊論文及評論。他被引用次數最多的論文,《對拉米夫定抗慢性B型肝炎病毒的一年期實驗》,被援引超過1200次。

作為一位敬業的師長,黎教授的本科生和研究生教學分別被授予最佳教師獎和最佳指導獎。作為學術領航者,他是1998至2009年度港大瑪麗醫院機構審查委員會主席,工程學院推廣及任期委員會委員長,和大學晉升選拔委員會委員。

王振宇

2008年就職

The Division of Gastroenterology of the Department of Medicine is a world-renowned centre of advanced and innovative research. It pioneered the world’s first stomach cancer prevention study using antibiotics and has had a significant impact on the management of stomach cancer worldwide. The division has also made other major contribution to science, in particular in relation to Helicobacter pylori-related diseases, gastro-esophageal reflux disease, and the prevention and screening of stomach and colon cancer.

The Division is the leading referral centre of gastroenterological and hepatological problems in Hong Kong, and frequently receives consultations from overseas centres.

Professor Wong is currently Director of the Simon K Y Lee Digestive Disease Centre and honorary consultant physician of Queen Mary Hospital. He graduated from The University of Hong Kong in 1989 and was awarded MD degree in 2000 and PhD degree in 2005. In 2001, he won the Outstanding Young Researcher Award at HKU and in 2005 he won the Outstanding Researcher Award.

Professor Wong is an internationally recognised leader in the research stomach cancer and gastro-esophageal reflux disease. He is the key force in the development of clinical, basic and translational research as well as clinical services in Gastroenterology at the University and Queen Mary Hospital. He also leads a team of scientists in laboratory research of apoptosis-related genes and gene therapy in gastric and colon cancers.

Through the findings of a long-term ground-breaking study in Fujian he has proven that stomach cancer is now preventable. The research programme discovered that this disease is caused by the Helicobacter pylori bacterium and that as a result of Professor Wong’s findings one third of patients can now be saved. He has launched an awareness campaign and plans to expand the scope of the project.

Professor Wong has published 19 book chapters, 286 original articles and 288 conference proceedings. He is the editor of the Journal of Gastroenterology and Hepatology, Associate Editor-in-chief of the Chinese Journal of Gastroenterology and serves as a member of the editorial boards of several international and national journals.

He is currently a member of the Colorectal Cancer Screening Committee of the World Organisation of Digestive Endoscopy (OMED) and the Guideline and Publication Committee of the World Gastroenterological Organisation (WGO-OMGE). Locally he serves as the Vice President of Hong Kong Society of Gastroenterology, and the Chairman of the Research Committee of the Hong Kong Digestive Foundation.

Professor Wong is regularly invited to give plenary lectures at international meetings and has served as visiting professors to Columbia University College of Physicians and Surgeons in New York, USA, University of Arizona, USA, Sun Yat-sen University in Guangzhou, Guangzhou Medical University, Shanghai Second Medical University, First Military Medical University in Guangzhou, Peking University First Hospital, Capital University of Medical Sciences of Beijing, Xiamen University, Huazhong University of Science and Technology in Wuhan, Fourth Military Medical University in Xian and Shanghai Jiao Tong University.

林兆鑫

2005年就職
Gastroenterology is the branch of medicine that studies, diagnoses and treats diseases and problems of the digestive system, including the esophagus, stomach, pancreas, liver and intestines. The accomplishments of Professor Lam firmly established the University of Hong Kong as a centre of advanced and innovative research in this area.

Professor Lam, who received his medical degree in 1967 from the University of Hong Kong and became its chair professor in 1984, is one of the world’s leading experts in gastroenterology. He has published nine books, thirty-five book chapters and over 300 papers in international journals.

Professor Lam devoted a life-time of research on peptic ulcer and gastric cancer. His team performed the world’s first double-blind placebocontrolled study to show that peptic ulcer could be cured by eradication of Helicobacter pylori, and the world’s first chemoprevention population study, conducted for ten years in Fujian, China, to show that eradication of this stomach germ could prevent stomach cancer.

For his achievements in medicine and gastroenterology, he was awarded the Officer of the Most Excellent Order of the British Empire in 1997. And in 2002, he delivered the Bockus Lecture and received the Bockus Medal, awarded every four years at the World Congress of Gastroenterology to a scientist in gastroenterology in recognition of the contributions of the highest order that his or her work has to the world.

Professor Lam is regarded as the doyen father of modern gastroenterology in this part of the world. Under his leadership, the Hong Kong Society of Gastroenterology was established in 1982,
the Asian Pacific Association of Gastroenterology was reformed in 1992 to become a modern and democratic organization, and the annual Asian Pacific Digestive Week was founded in 2001.

Professor Lam is the Founding Editor of the Journal of Gastroenterology & Hepatology, and has served on the editorial board of more than twenty international journals. He was the President of the Asia Pacific Association of Gastroenterology (2000-2004), and is the current Chairman of the Research Advisory Committee of the World Organization of Gastroenterology.

He has also served as a Guest Professor at a number of leading medical institutions in China, including the Department of Medicine of the Beijing Medical College, the Shanghai Second Medical College, Xinjiang Medical University, Memorial Hospital of Sun Yat-Sen University of Medical Sciences and Shanghai Fudan University. Since 1981, Professor Lam has been the Director of the Centre of Alimentary Research & Education (CARE) at the University of Hong Kong. He founded the China Ulcer Research Group, and has served as its Chairman since 1987.

Professor Lam is currently the Vice-Chairman of the Hong Kong Liver Foundation, Trustee of the Journal of Gastroenterology & Hepatology Foundation, Vice Chairman of the Hong Kong Digestive Foundation, Trustee of Cheng Si Yuan (China-International) Hepatitis Research Foundation, and member of the Board of Hospital Authority.